Submitted by Anonymous (not verified) on 17 October 2025 - 16:32
Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 1, Status: Authorised